NeuroOne Medical Technologies Corporation
Income Statement
| Line Item | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|
| Revenue | $1.2K | $921 | $5.4K | $1.2K |
| Cost of Revenue | — | $0 | $2.1K | — |
| Gross Profit | $1.2K | $921 | $3.3K | $1.2K |
| Gross Margin | 100.0% | 100.0% | 60.4% | 100.0% |
| Operating Expenses | ||||
| Research & Development | — | — | — | — |
| SG&A Expense | $26.3K | $2.7K | $30.7K | $7.2K |
| Operating Income | $-25.1K | $-13.7K | — | — |
| Operating Margin | -2,009.0% | -1,491.1% | — | — |
| Interest Expense | — | $-227 | $-176 | — |
| Pretax Income | $-30.6K | $-14.0K | — | — |
| Income Tax Expense | — | — | — | — |
| Net Income | $-30.6K | $-14.0K | $-27.6K | $-6.0K |
| Net Margin | -2,446.3% | -1,515.7% | -511.4% | -517.9% |
| EPS (Basic) | $-0.01 | $0.00 | $-0.01 | — |
| EPS (Diluted) | $-0.01 | $0.00 | $-0.01 | — |
| Shares Outstanding (Basic) | 5.1M | 5.1M | 4.6M | 4.3M |
| Shares Outstanding (Diluted) | 5.1M | 5.1M | 4.6M | 4.3M |
| Dividends Per Share | — | — | — | — |